Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $129.90 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $54.59 | 1 | $0 (2018) |
| EMD Serono, Inc. | $34.04 | 2 | $0 (2023) |
| EISAI INC. | $24.59 | 1 | $0 (2022) |
| InSightec,Inc | $16.68 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $34.04 | 2 | EMD Serono, Inc. ($34.04) |
| 2022 | $24.59 | 1 | EISAI INC. ($24.59) |
| 2021 | $16.68 | 1 | InSightec,Inc ($16.68) |
| 2018 | $54.59 | 1 | Biogen, Inc. ($54.59) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $16.29 | General |
| Category: Neurology | ||||||
| 04/14/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: Neurology | ||||||
| 06/01/2022 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $24.59 | General |
| Category: Neurology | ||||||
| 11/10/2021 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: Neurology | ||||||
| 02/08/2018 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | Cash or cash equivalent | $54.59 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 235 | 558 | $73,740 | $27,578 |
| 2021 | 10 | 508 | 927 | $122,992 | $57,806 |
| 2020 | 8 | 307 | 661 | $97,822 | $35,420 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 219 | $45,990 | $17,403 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 130 | $19,560 | $7,525 | 38.5% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 39 | 39 | $1,560 | $1,544 | 99.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 11 | 14 | $2,240 | $557.03 | 24.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 11 | 71 | $2,180 | $299.48 | 13.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 61 | 85 | $2,210 | $249.24 | 11.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 434 | $91,140 | $38,904 | 42.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 97 | $14,550 | $6,445 | 44.3% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 95 | 95 | $3,800 | $3,800 | 100.0% |
| 11106 | Incisional biopsy of single skin lesion | Office | 2021 | 14 | 20 | $4,100 | $2,496 | 60.9% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 58 | 58 | $2,320 | $2,320 | 100.0% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 64 | 64 | $1,792 | $1,314 | 73.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 64 | 64 | $2,400 | $1,136 | 47.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 15 | 15 | $600.00 | $600.00 | 100.0% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 15 | 15 | $600.00 | $600.00 | 100.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 56 | 65 | $1,690 | $192.00 | 11.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 355 | $74,550 | $26,123 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 43 | 85 | $12,750 | $4,416 | 34.6% |
| 11106 | Incisional biopsy of single skin lesion | Office | 2020 | 13 | 18 | $3,690 | $2,089 | 56.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 59 | 61 | $2,281 | $1,066 | 46.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 53 | 53 | $1,484 | $1,038 | 69.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 25 | 31 | $1,240 | $412.12 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 30 | 47 | $1,222 | $140.16 | 11.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 11 | 11 | $605.00 | $135.70 | 22.4% |
About Dr. Fayyaz Mahmood, MD
Dr. Fayyaz Mahmood, MD is a Internal Medicine healthcare provider based in Gresham, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790777050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fayyaz Mahmood, MD has received a total of $129.90 in payments from pharmaceutical and medical device companies, with $34.04 received in 2023. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($129.90).
As a Medicare-enrolled provider, Mahmood has provided services to 1,050 Medicare beneficiaries, totaling 2,146 services with total Medicare billing of $120,804. Data is available for 3 years (2020–2022), covering 24 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Gresham, OR
- Active Since 08/22/2005
- Last Updated 11/17/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790777050
Products in Payments
- TECFIDERA (Drug) $54.59
- MAVENCLAD (Drug) $34.04
- Fycompa (Drug) $24.59
- Exablate (Device) $16.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gresham
Edward Cheng, M.d,, M.D,
Internal Medicine — Payments: $39,176
Dr. Avnish Tripathi, M.d., Ph.d., M.p.h, M.D., PH.D., M.P.H
Internal Medicine — Payments: $12,554
Jennifer Rodriguez, M.d, M.D
Internal Medicine — Payments: $10,858
Steven Maness, M.d, M.D
Internal Medicine — Payments: $6,102
Angela Gibbs, Md, MD
Internal Medicine — Payments: $1,551
Craig Davis, Md, MD
Internal Medicine — Payments: $804.46